To evaluate the clinical significance of BRIP1 expression, patients with rectal and colon cancer were stratified into high- and low-expression subgroups based on the median BRIP1 expression level (Table 1 and Table 2). This evidence concerns the gene BRIP1 and malignant colon neoplasm.